• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    5.71 Down 0.47(7.61%) Feb 12, 3:59PM EST
    Prev Close:6.18
    Open:5.74
    Bid:3.75 x 200
    Ask:N/A
    1y Target Est:17.50
    Beta:2.08308
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:5.34 - 5.90
    52wk Range:5.34 - 28.97
    Volume:738,176
    Avg Vol (3m):617,686
    Market Cap:165.23M
    P/E (ttm):N/A
    EPS (ttm):-1.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 7.61%165.23M
    PFEUp 0.79%181.25B
    AZNUp 1.75%74.98B
    MRKUp 0.37%136.97B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.09
    Quarterly EPS Est (Dec-15) :-0.84
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback